Literature DB >> 15604246

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Raanan Berger1, Phillip G Febbo, Pradip K Majumder, Jean J Zhao, Shayan Mukherjee, Sabina Signoretti, K Thirza Campbell, William R Sellers, Thomas M Roberts, Massimo Loda, Todd R Golub, William C Hahn.   

Abstract

Androgen ablation is the primary treatment modality for patients with metastatic prostate cancer; however, the role of androgen receptor signaling in prostate cancer development remains enigmatic. Using a series of genetically defined immortalized and tumorigenic human prostate epithelial cells, we found that introduction of the androgen receptor induced differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of organ-confined prostate cancer when placed in the prostate microenvironment. Moreover, androgen receptor expression converted previously androgen-independent, tumorigenic prostate epithelial cells into cells dependent on testosterone for tumor formation. These observations indicate that androgen receptor expression is oncogenic and addictive for the human prostate epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604246     DOI: 10.1158/0008-5472.CAN-04-2938

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  81 in total

1.  Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland.

Authors:  L Jiang; F Ivich; S Tahsin; M Tran; S B Frank; C K Miranti; Y Zohar
Journal:  Biomicrofluidics       Date:  2019-11-20       Impact factor: 2.800

2.  Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

Authors:  Hui Gao; Xuesong Ouyang; Whitney A Banach-Petrosky; William L Gerald; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

Review 3.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.

Authors:  Zhihu Ding; Chang-Jiun Wu; Gerald C Chu; Yonghong Xiao; Dennis Ho; Jingfang Zhang; Samuel R Perry; Emma S Labrot; Xiaoqiu Wu; Rosina Lis; Yujin Hoshida; David Hiller; Baoli Hu; Shan Jiang; Hongwu Zheng; Alexander H Stegh; Kenneth L Scott; Sabina Signoretti; Nabeel Bardeesy; Y Alan Wang; David E Hill; Todd R Golub; Meir J Stampfer; Wing H Wong; Massimo Loda; Lorelei Mucci; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2011-02-02       Impact factor: 49.962

5.  CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts.

Authors:  Congfeng Xu; Yanhui H Zhang; Muthusamy Thangavel; Mekel M Richardson; Li Liu; Bin Zhou; Yi Zheng; Rennolds S Ostrom; Xin A Zhang
Journal:  FASEB J       Date:  2009-06-04       Impact factor: 5.191

6.  Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Authors:  Bobby Bhatia; Ming Jiang; Mahipal Suraneni; Lubna Patrawala; Mark Badeaux; Robin Schneider-Broussard; Asha S Multani; Collene R Jeter; Tammy Calhoun-Davis; Limei Hu; Jianhua Hu; Spiridon Tsavachidis; Wei Zhang; Sandy Chang; Simon W Hayward; Dean G Tang
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

7.  A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.

Authors:  Pradip K Majumder; Chiara Grisanzio; Fionnuala O'Connell; Marc Barry; Joseph M Brito; Qing Xu; Isil Guney; Raanan Berger; Paula Herman; Rachel Bikoff; Giuseppe Fedele; Won-Ki Baek; Shunyou Wang; Katharine Ellwood-Yen; Hong Wu; Charles L Sawyers; Sabina Signoretti; William C Hahn; Massimo Loda; William R Sellers
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

8.  Modulation of TGF-β-inducible hypermotility by EGF and other factors in human prostate epithelial cells and keratinocytes.

Authors:  Wei Wei; Patricia D Barron; James G Rheinwald
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-02       Impact factor: 2.416

9.  Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.

Authors:  Franklin W Huang; Juan Miguel Mosquera; Andrea Garofalo; Coyin Oh; Maria Baco; Ali Amin-Mansour; Bokang Rabasha; Samira Bahl; Stephanie A Mullane; Brian D Robinson; Saud Aldubayan; Francesca Khani; Beerinder Karir; Eejung Kim; Jeremy Chimene-Weiss; Matan Hofree; Alessandro Romanel; Joseph R Osborne; Jong Wook Kim; Gissou Azabdaftari; Anna Woloszynska-Read; Karen Sfanos; Angelo M De Marzo; Francesca Demichelis; Stacey Gabriel; Eliezer M Van Allen; Jill Mesirov; Pablo Tamayo; Mark A Rubin; Isaac J Powell; Levi A Garraway
Journal:  Cancer Discov       Date:  2017-05-17       Impact factor: 39.397

10.  MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy.

Authors:  Bala S Balakumaran; Alessandro Porrello; David S Hsu; Wayne Glover; Adam Foye; Janet Y Leung; Beth A Sullivan; William C Hahn; Massimo Loda; Phillip G Febbo
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.